1. Home
  2. NTRA vs SBAC Comparison

NTRA vs SBAC Comparison

Compare NTRA & SBAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • SBAC
  • Stock Information
  • Founded
  • NTRA 2003
  • SBAC 1989
  • Country
  • NTRA United States
  • SBAC United States
  • Employees
  • NTRA N/A
  • SBAC N/A
  • Industry
  • NTRA Medical Specialities
  • SBAC Real Estate Investment Trusts
  • Sector
  • NTRA Health Care
  • SBAC Real Estate
  • Exchange
  • NTRA Nasdaq
  • SBAC Nasdaq
  • Market Cap
  • NTRA 24.9B
  • SBAC 20.2B
  • IPO Year
  • NTRA 2015
  • SBAC 1999
  • Fundamental
  • Price
  • NTRA $192.81
  • SBAC $190.42
  • Analyst Decision
  • NTRA Strong Buy
  • SBAC Buy
  • Analyst Count
  • NTRA 17
  • SBAC 15
  • Target Price
  • NTRA $196.24
  • SBAC $244.13
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • SBAC 1.1M
  • Earning Date
  • NTRA 11-07-2025
  • SBAC 11-03-2025
  • Dividend Yield
  • NTRA N/A
  • SBAC 2.33%
  • EPS Growth
  • NTRA N/A
  • SBAC 71.76
  • EPS
  • NTRA N/A
  • SBAC 8.15
  • Revenue
  • NTRA $1,964,250,000.00
  • SBAC $2,724,524,000.00
  • Revenue This Year
  • NTRA $24.17
  • SBAC $6.84
  • Revenue Next Year
  • NTRA $15.57
  • SBAC $2.41
  • P/E Ratio
  • NTRA N/A
  • SBAC $23.36
  • Revenue Growth
  • NTRA 44.38
  • SBAC 1.82
  • 52 Week Low
  • NTRA $119.29
  • SBAC $185.45
  • 52 Week High
  • NTRA $198.99
  • SBAC $245.16
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 68.54
  • SBAC 38.07
  • Support Level
  • NTRA $183.88
  • SBAC $187.53
  • Resistance Level
  • NTRA $198.99
  • SBAC $199.87
  • Average True Range (ATR)
  • NTRA 6.55
  • SBAC 4.34
  • MACD
  • NTRA 1.09
  • SBAC 0.55
  • Stochastic Oscillator
  • NTRA 80.07
  • SBAC 34.32

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About SBAC SBA Communications Corporation

SBA Communications owns a portfolio of about 45,000 wireless towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, who install equipment to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by the top few mobile carriers. It owns more than 17,000 towers in the US, which account for about 75% of leasing revenue. Internationally, SBA's largest presence is in Brazil, where it owns roughly 10,000 towers. SBA operates as a real estate investment trust.

Share on Social Networks: